Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini

被引:7
作者
Chastain, Elizabeth C. [1 ]
Oliva, Irma V. [1 ]
Osunkoya, Adeboye O. [1 ,2 ,3 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA
[3] Emory Winship Canc Inst, Atlanta, GA USA
关键词
Colonisation of prostatic ducts and acini; HMWCK; p63; prostatic stromal invasion; urothelial carcinoma; TRANSITIONAL-CELL-CARCINOMA; BLADDER-CANCER; INVOLVEMENT; PATTERNS;
D O I
10.1097/PAT.0b013e3283511c73
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: To evaluate the utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini which may be challenging on H&E, especially for general pathologists who may occasionally encounter these cases. Methods: A search of surgical pathology and consultation files was made for cystoprostatectomy specimens with confirmed urothelial carcinoma with prostatic stromal invasion. Intensity for both p63 and high molecular weight cytokeratin within the tumour cells were scored as negative/weak or strong. Results: A total of 34 cases were identified, 23 (68%) of which had associated foci of urothelial carcinoma with colonisation of prostatic ducts and acini. Mean patient age was 68.5 years (range 44-88 years). In all cases, basal cells of benign prostatic glands showed strong staining for both p63 and high molecular weight cytokeratin. Seventeen of 34 cases (50%) of urothelial carcinoma showed no or weak expression of high molecular weight cytokeratin in the tumour cells. The other 17 cases (50%) of urothelial carcinoma showed strong expression of high molecular weight cytokeratin in the tumour cells. Fourteen of 34 cases (41%) showed negative or weak expression of p63 in tumour cells. Twenty of 34 cases (59%) showed strong expression of p63 in tumour cells. In the 14 of 34 cases (41%) and 17 of 34 cases (50%) which showed negative/weak expression of p63 and high molecular weight cytokeratin, respectively, in the tumour cells, the positive staining of the basal cells by p63 and high molecular weight cytokeratin in the benign prostatic glands and acini or those colonised by urothelial carcinoma, aided in the distinction from urothelial carcinoma with prostatic stromal invasion. In the remaining 20 of 34 cases (59%) and 17 of 34 cases (50%) in which the tumour cells showed strong expression of p63 and high molecular weight cytokeratin, respectively, larger malignant tumour cells and smaller benign basal cells of the prostatic glands and acini were highlighted with these markers, and were easily distinguishable. Conclusion: Our study suggests that p63 and high molecular weight cytokeratin may be utilised in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 13 条
[1]  
Edge S.B., 2010, AJCC cancer staging manual, V649
[2]  
Esrig D, 1996, J UROLOGY, V156, P1117
[3]  
GOWN AM, 1984, AM J PATHOL, V114, P309
[4]   Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer [J].
Lerner, Seth P. ;
Shen, Steven .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (05) :481-485
[5]   Prostatic biology, histologic patterns and clinical consequences of transitional cell carcinoma [J].
Lerner, Seth P. ;
Colen, John ;
Shen, Steven .
CURRENT OPINION IN UROLOGY, 2008, 18 (05) :508-512
[6]   Transitional cell carcinoma involving the prostate: A clinicopathological retrospective study of 76 cases [J].
Ngninkeu, BN ;
Lorge, F ;
Moulin, P ;
Jamart, J ;
Van Cangh, PJ .
JOURNAL OF UROLOGY, 2003, 169 (01) :149-152
[7]   Urothelial carcinoma of the bladder with transmural and direct prostatic stromal invasion: does extent of stromal invasion significantly impact patient outcome? [J].
Oliva, Irma V. ;
Smith, Stacey L. ;
Chen, Zhengjia ;
Osunkoya, Adeboye O. .
HUMAN PATHOLOGY, 2011, 42 (01) :51-56
[8]   Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement [J].
Pagano, F ;
Bassi, P ;
Ferrante, GLD ;
Piazza, N ;
Abatangelo, G ;
Pappagallo, GL ;
Garbeglio, A .
JOURNAL OF UROLOGY, 1996, 155 (01) :244-247
[9]   p63 protein expression is rare in prostate adenocarcinoma: Implications for cancer diagnosis and carcinogenesis [J].
Parsons, JK ;
Gage, WR ;
Nelson, WG ;
De Marzo, AM .
UROLOGY, 2001, 58 (04) :619-624
[10]   Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: Implications for possible apical sparing surgery [J].
Revelo, MP ;
Cookson, MS ;
Chang, SS ;
Shook, MF ;
Smith, JA ;
Shappell, SB .
JOURNAL OF UROLOGY, 2004, 171 (02) :646-651